Skip to main content

Table 2 Data extracted from the included studies

From: Robotic-assisted versus laparoscopic colorectal surgery: a meta-analysis of four randomized controlled trials

Study Group N Operation time, minutes EBL, ml Open conversion events, n Time to recovery of bowel function, d Complication events, n LOS, d Proximal margin, cm Distal margin, cm Harvested lymph nodes, n Total hospital cost, $
Baik SH RCS 18 217.1 (51.6) N/A 0 1.8 (0.4) 4 6.9 (1.3) 10.9 (1.7) 4 (1.1) 20.1 (9.1) N/A
LCS 18 204.3 (56.9) 2 2.4 (1.3) 1 8.7 (1.7) 10.3 (3.6) 3.7 (1.1) 17.4 (10.6)
Jimenez RR RCS 28 159.4 (43.5) N/A 2 N/A 4 N/A N/A 4.8 (1.6) 17.6 (9.2) N/A
LCS 28 135.1 (29.2) 2 4 3.8 (0.7) 14.9 (8.7)
Park JS RCS 35 195 (41) 35.8 (26.3) 0 2.6 (1.4) 6 7.9 (4.1) 18.6 (7.3) 18 (9) 29.9 (14.7) 12,235 (1,907.9)
LCS 35 130 (43) 56.8 (31.3) 0 2.9 (2.2) 7 8.3 (4.2) 18.3 (9.9) 14.5 (8) 30.8 (13.3) 10,320.7 (1,607.7)
Patriti A RCS 29 202 (12) 137.4 (156) 0 N/A 9 11.9 (7. 5) N/A 2.1 (0.9) 10.3 (4) N/A
LCS 37 208 (7) 127 (169) 7 7 9.6 (6.9) 4.5 (7.2) 11.2 (5)
  1. Values are expressed as mean (SD) or number. EBL, estimated blood loss; LOS, length of hospital stay; N/A, not applicable; RCS, robotic-assisted colorectal surgery; LCS, laparoscopic colorectal surgery.